GlassScriptPhysician profile
Oliver Acosta
NPI 1861050700
$1,245.65
in general payments reported to CMS, 2019-2025
9 companies · $403 in 2025
The $403 reported for 2025 was more than what 75% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $165 · 2023: $418 · 2024: $70.09 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.98 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Microtransponder, INC. | $205.72 | 2025 | |
| Allergan, INC. | $124.16 | 2021 | |
| Grt US Holding, INC. | $114.58 | 2022 | |
| Merz Pharmaceuticals, LLC | $67.24 | 2023-2024 | Xeomin |
| Saol Therapeutics INC. | $47.78 | 2021 | |
| Coloplast Corp | $30.96 | 2021-2022 | |
| Intra-Sana Laboratories | $16.05 | 2025 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Piramal Critical Care | $13.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Acosta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.